United States-Israel Alzheimer's Disease Cooperation Act
Official title: To authorize the Secretary of Health and Human Services to award grants for Alzheimer's disease research.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the House Committee on Energy and Commerce.
United States-Israel Alzheimer's Disease Cooperation Act
This bill directs the Department of Health and Human Services (HHS) to establish a program of grants to support research on the development and commercialization of tools, treatments, and cures for Alzheimer's disease and other dementias. Supported projects must be joint ventures between U.S. and Israeli non-governmental entities or the U.S. and Israeli governments.
HHS must establish an advisory board to monitor the method by which grants are awarded and to provide performance reviews of actions taken to carry out this bill.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 5645: United States-Israel Alzheimer's Disease Cooperation Act. 114th Congress. Open America. https://openamerica.io/bill/114-HR-5645/
"H.R. 5645: United States-Israel Alzheimer's Disease Cooperation Act." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-5645/.
H.R. 5645, 114th Cong. (2026), https://openamerica.io/bill/114-HR-5645/.
[H.R. 5645: United States-Israel Alzheimer's Disease Cooperation Act](https://openamerica.io/bill/114-HR-5645/)